Daniel L. Menichella, Senior VP, Business Development at Talecris Biotherapeutics Holdings Corp. (V9SNS*IJ), sold 100,000 shares at $22.05 ($2.2M) on 2010-08-30, disclosed to the SEC on 2010-09-01.
Scheduled sale ($2.2M) by Senior VP, Business Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| AGTC | SELL | 2014-12-23 | $187K | — | Filing → |